News
-
Hollywood, Harris join MA Board
- Mon Oct 19
Boehringer Ingelheim GM brings strong industry experience to the Board as a former Deputy Chair finally breaks the curse for Novartis.
Read more -
Sandoz boss wants to bring 89 more biosims by 2040
- Mon Oct 19
Biosimilars may launch in Australia even without a reference brand, Sandoz CEO Clint Holland saying it’s not his preferred access path, but he will do it.
Read more -
PBAC opens the door to broader PBS access
- Mon Oct 19
While there were more winners than losers at the spring meet, some companies may still struggle to make their recommendations work.
Read more -
We’ve run out of money, so don’t bother asking
- Mon Oct 19
OP-ED: What happens when the need is there but the cupboard is bare? Labor’s claim to be the party of Medicare and the PBS is looking shaky as funding dries up.
Read more -
TGA designations bring rare-disease therapies closer
- Mon Oct 19
Priority and provisional pathways lead a new group of therapies spanning cancer, kidney disease, neurology, infection and inherited disorders.
Read more -
England’s genomics ambition makes Australia’s look small
- Fri Oct 16
NHS Chief Scientific Officer Professor Dame Sue Hill outlines an ambitious vision to integrating genomics from pregnancy to end-of-life care as Australia targets marginalised populations.
Read more -
MedNews editor wins national award
- Fri Oct 16
MedNews editor Megan Brodie received the German Grant for Journalism 2026 at a presentation at the National Press Club of Australia in Canberra.
Read more -
Health spending rising, but the Feds aren’t paying
- Fri Oct 16
Australia spent $291 billion on health in 2024–25, but with the Albanese Government cutting its spend, who’s increasingly picking up the tab?
Read more